The major finding of this study is that S1P4 is linked with poor prognosis in ER− breast cancer patients as evidenced by shorter disease-free survival and disease-specific survival of patients who have high S1P4 expression in their tumours compared with those that have low receptor expression. Here, S1PR4 is linked to breast carcinoma.